These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1241167)

  • 21. Conformational properties of phospholipases A2. Secondary-structure prediction, circular dichroism and relative interface hydrophobicity.
    Dufton MJ; Eaker D; Hider RC
    Eur J Biochem; 1983 Dec; 137(3):537-44. PubMed ID: 6662109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STUDIES ON HYDROLYSIS OF CARDIOLIPIN BY SNAKE VENOM PHOSPHOLIPASE A.
    OKUYAMA H; NOJIMA S
    J Biochem; 1965 Apr; 57():529-38. PubMed ID: 14318082
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on phospholipase A inhibitor in blood plasma. I. Purification and characterization of phospholipase A inhibitor in bovine plasma.
    Miwa M; Kubota I; Ichihashi T; Motojima H; Matsumoto M
    J Biochem; 1984 Sep; 96(3):761-73. PubMed ID: 6501263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence of a cDNA encoding a snake venom phospholipase A2.
    Guignery-Frelat G; Ducancel F; Ménez A; Boulain JC
    Nucleic Acids Res; 1987 Jul; 15(14):5892. PubMed ID: 3615209
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis of cell-impermeable inhibitor of phospholipase A2.
    Yedgar S; Reisfeld N; Dagan A
    FEBS Lett; 1986 May; 200(1):165-8. PubMed ID: 2422059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
    Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
    Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
    Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM
    Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic comparison of phospholipases A present in Hymenoptera insect venoms.
    Nair BC; Nair C; Denne S; Wypych J; Arbesman CE; Elliott WB
    J Allergy Clin Immunol; 1976 Jul; 58(1 PT 1):101-9. PubMed ID: 947973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone directly inhibits snake venom phospholipase A.
    Kato N; Halprin KM; Matsuo S; Taylor JR
    Biochem Biophys Res Commun; 1985 Jul; 130(2):761-7. PubMed ID: 4026856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromuscular action of venom from the South American colubrid snake Philodryas patagoniensis.
    Carreiro da Costa RS; Prudêncio L; Ferrari EF; Souza GH; de Mello SM; Prianti Júnior AC; Ribeiro W; Zamunér SR; Hyslop S; Cogo JC
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jul; 148(1):31-8. PubMed ID: 18455482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linear B-cell epitopes in BthTX-1, BthTX-II and BthA-1, phospholipase A₂'s from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom.
    De-Simone SG; Napoleão-Pego P; Teixeira-Pinto LA; Santos JD; De-Simone TS; Melgarejo AR; Aguiar AS; Marchi-Salvador DP
    Toxicon; 2013 Sep; 72():90-101. PubMed ID: 23792452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crotalus adamanteus phospholipase A2-alpha: subunit structure. NH2-terminal sequence, and homology with other phospholipases.
    Tsao FH; Keim PS; Henrikson RL
    Arch Biochem Biophys; 1975 Apr; 167(2):706-17. PubMed ID: 1124937
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraspecific differences in the immunochemical reactivity and neutralization of venom from Argentinean Bothrops (Rhinocerophis) alternatus by specific experimental antivenoms.
    Lanari LC; Alagón A; Costa de Oliveira V; Laskowicz RD; Boyer L; Lago NR; Alejandro A; de Roodt AR
    Toxicon; 2014 Jul; 85():31-45. PubMed ID: 24769139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phospholipase A2 activity and substrate specificity of snake venom presynaptic toxins.
    Napias C; Heilbronn E
    Biochemistry; 1980 Mar; 19(6):1146-51. PubMed ID: 7370229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant activity and plasma phosphatidylserine hydrolysis by snake venom phospholipases A2.
    Condrea E; Yang CC; Rosenberg P
    Thromb Haemost; 1983 Apr; 49(2):151. PubMed ID: 6868012
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxicity of endotoxin and snake venom in the hagfish.
    PAPERMASTER BW; CONDIE RM; GOOD RA; JENSEN D
    Nature; 1962 Jul; 195():84. PubMed ID: 14483721
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple and high yield purification of Crotalus adamanteus phospholipases A2.
    Wells MA
    Biochim Biophys Acta; 1975 Mar; 380(3):501-5. PubMed ID: 237535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of crystals of two venom phospholipases A2.
    Pasek M; Keith C; Feldman D; Sigler PB
    J Mol Biol; 1975 Sep; 97(3):395-7. PubMed ID: 1181469
    [No Abstract]   [Full Text] [Related]  

  • 40. [THE MODE OF ACTION OF PHOSPHOLIPASE A FROM SNAKE VENOM ON ELAIDIN SUBSTRATES].
    DAUVILLIER P; DE HAAS GH; VAN DEENENL ; RAULIN J
    C R Hebd Seances Acad Sci; 1964 Dec; 259():4865-7. PubMed ID: 14254951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.